Literature DB >> 19679052

Immunohistochemical analysis of selected molecular markers in esophagus precancerous, adenocarcinoma and squamous cell carcinoma in Iranian subjects.

Abdolamir Allameh1, Yousef Rasmi, Siavosh Nasseri-Moghaddam, Seyed Mohammad Tavangar, Roya Sharifi, Masoud Sadreddini.   

Abstract

BACKGROUND: The molecular and cellular mechanisms linking chronic inflammation and gastrointestinal malignancy are not known with certainty. AIM: To investigate changes in potential causative factors during progression of esophagus cancer in a population living in high-risk area in Iran.
SUBJECTS: Formalin-fixed, paraffin-embedded esophageal specimens (n=87) from patients with gastroesophageal reflux disease (GERD), Barrett's metaplasia, adenocarcinoma (ADC) and squamous cells carcinoma (SCC) were collected based on their pathological diagnosis.
METHODS: Immunohistochemical (IHC) technique was used to study tissue accumulation of P53, P21, cyclooxygenase-2 (COX-2), glutathione S-transferase-P (GST-Pi) and nitrotyrosine (NT) in patients and controls.
RESULTS: P53 expression was not detected in esophageal tissues from normal and GERD samples, whereas it was found positive in Barrett's, ADC, and SCC samples. P21 positive sample was relatively higher in ADC patients as compared to that in SCC (ADC: 52.6%; SCC: 25%). GST-Pi expression was equally accumulated in all the samples. NT was predominantly expressed in ADC (72.7%). COX-2 expression was significantly higher in Barrett's (60.0%) and ADC (66.6%) as compared to that in GERD, SCC and normal. These data were further confirmed by detecting the scores of immunostainings in all the positive samples.
CONCLUSION: The pathological changes in ADC and SCC samples which were associated with increasing frequency of NT and COX-2 provides further evidence for involvement of these inflammatory factors in progression of esophagus cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19679052     DOI: 10.1016/j.canep.2009.05.002

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  5 in total

1.  Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma.

Authors:  Matthew F Buas; Haiwei Gu; Danijel Djukovic; Jiangjiang Zhu; Lynn Onstad; Brian J Reid; Daniel Raftery; Thomas L Vaughan
Journal:  Metabolomics       Date:  2017-01-20       Impact factor: 4.290

2.  Evaluating the Correlation Between the Survival Rate of Patients with Esophageal Squamous Cell Carcinoma and Expression of p53 and Cyclin D1 Biomarkers Along with Other Prognostic Factors.

Authors:  Nazanin Saemi; Jalaleddin Khoshnevis; Mohammad Esmaeil Akbari; Alipasha Meysamie; Alireza Korourian; Barmak Gholizadeh; Leila Larijani; Afshin Moradi; Masoud Baikpour; Maryam Baikpour; Hanieh Zham
Journal:  J Gastrointest Cancer       Date:  2018-03

3.  Is tumor length a prognostic indicator for esophageal squamous cell carcinoma? A single larger study among Chinese patients.

Authors:  Ming-Quan Ma; Zhen-Tao Yu; Peng Tang; Hong-Jing Jiang; Xi-Jiang Zhao; Jian-Guo Zhang; Da-Wang Qu; Qing-Wen Jin; Xi-Zeng Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Studies on the Contribution of Cox-2 Expression in the Progression of Oral Squamous Cell Carcinoma and H-Ras Activation.

Authors:  Abdolkarim Moazeni-Roodi; Abdolamir Allameh; Iraj Harirchi; Maziar Motiee-Langroudi; Ata Garajei
Journal:  Pathol Oncol Res       Date:  2016-09-15       Impact factor: 3.201

5.  Radical decisions in cancer: redox control of cell growth and death.

Authors:  Rosa M Sainz; Felipe Lombo; Juan C Mayo
Journal:  Cancers (Basel)       Date:  2012-04-25       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.